All patients with SSc were anti-nuclear antibodies (ANA) positive, 47 (35.9%) had anti-centromeric proteins (CENP) antibodies, and 57 (43.5%) had anti-Topoisomerase I. The presence of ILD was observed in 78 (59.5%) patients. The gene discussed is BTG3; the disease is interstitial lung disease.